Loading

Female Viagra

By F. Gunock. Thomas Cooley Law School.

You need JavaScript enabled to view it Discover the reasons why some people commit suicide buy discount female viagra 50 mg. There are order female viagra 50mg fast delivery, of course 50 mg female viagra overnight delivery, many reasons one might commit suicide including: due to a clinical depression, as a result of drug or alcohol abuse or misuse ; experiencing a life disappointment or frustration, to "get back" at someone perceived as causing harm; or an inability to cope with disease, loneliness or pain. There are many other individual experiences that might lead one to attempt suicide, some of which are not easily understood by others. If desire to die is not the reason, the behaviors are called "gestures," but sometimes even these "gestures" can accidentally result in death (actual suicide). Coping with suicidal activity or thinking, or suicide itself is always difficult. Even with suicidal "gestures," the thinking that results in those behaviors may be important to understand and treat. Death caused by any means can be difficult to survive, with feelings of loss, frustration, depression, and even anger being common emotions experienced by survivors. But suicide adds even more difficulty, with survivors wondering if they could have recognized the symptoms leading up to the event. Many survivors experience shame, in addition to the guilt of not stopping the action. Others experience anger, frustration in addition to the sense of loss. It is also important to realize that when parents suicide, it is more likely that children will ultimately suicide as well. And suicide is a behavior that frequently lives forever in the history of a family. I explain to my patients that suicide is not a legacy one wants to burden their family with. You can watch the HealthyPlace Mental Health TV Show live (5:30p PT, 7:30 CT, 8:30 ET) and on-demand on our website. Written by John McManamyMany with bipolar disorder have suicidal thoughts. Some fifteen percent of us who suffer from major depression will die by our own hand. And many more still will die by "accident" or "slow suicide" through reckless behavior or personal abuse and neglect. According to the Centers for Disease Control, suicide is the 9th leading cause of death in the US (more than 30,000 a year). Women will make the most attempts, but men will be by far more successful, by a margin of four to one. In teens and young adults, suicide is the 3rd leading cause of death, after accidents and homicides, more than all natural diseases combined. It affects both the strong and the weak, the rich and the poor. As have successful business people and artists and mothers and those with everything to live for. At any given moment, five percent of the general population is suffering from a major depressive episode. Over the course of a lifetime, major depression will strike 20% of the population, numbers comparable to cancer and heart disease. Those with major depression have an 85% survival rate, but the prospect of finding ourselves in the lucky majority brings us only small relief. The experience has exposed us to our worst vulnerabilities, and deep inside we no longer trust what tomorrow may bring. We may still be walking and breathing, but we have been as close inside death as this side of life permits, and our minds will never let us forget it. We ponder the fates of the unlucky minority, and sometimes we say a prayer. We contemplate the tortures their brains exposed them to, and know for a fact that no God would ever hold judgement against them. For the time being we are the lucky ones, but tomorrow that may change. Still, we do have a certain amount of control in managing tomorrow. We who have survived know what we are up against - and can plan accordingly. Following are some common sense guidelines:Cultivate friends or family members you can call on should you find yourself in crisis. If you have no friends or family you can trust, then seek out a support group, live or online. About posting your cry for help on the Internet: choose your site or mailing list very carefully. If you are new and posting to a very busy list, your appeal may be lost in the shuffle. At the opposite end, your message may go completely unread on bulletin boards with little or no traffic. It may take a few weeks before you establish a presence on a particular list or board. By then, you will probably be on email or ICQ terms with some of the members. Look up the numbers of various local suicide hotlines and keep them where you can find them. Familiarize yourself with the Internet crisis and suicide sites and bookmark the ones you like. Establish a close relationship with your doctor or psychiatrist. Ask yourself: is this someone you can call on in the middle of the night?

Sometimes a look or expression from someone brings up feelings that are unbearable buy 100mg female viagra overnight delivery. When something starts to come up that is unbearable buy female viagra 100mg otc, the binge eating begins buy 50 mg female viagra otc. Your feelings and your associations are being remembered and expressed through your body. So first we get in touch with the body and bear what the experience is. Often we (and I say we, because this is a human experience not exclusive to people with eating disorders) feel something, and then use our clever minds to try to come up with a reason, a local external reason for our experience. So again and again, the healing effort goes into postponing, waiting, being still, staying with whatever we feel until eventually it passes or we get a helpful association to bring to our therapist to work on. Joanna: Healing from eating disorders proceeds in stages. Not stages where anyone could criticize themselves for skipping stages or going out of order, but stages nonetheless. Someone in early eating disorder recovery is often quite terrified. She or he can feel that the eating disorder is just waiting to jump out at any time and take over. So certain foods that have been classic binge foods are emotionally loaded. Also, going back to a previous question, the physicality of the binge food, the way it feels in the mouth going down, the taste, the consistency, are all familiar physical sensations that can invite a person back into old habits. But, at some later time, we want to revisit those foods. You could probably live your life without ever eating those particular foods again. So when you are ready to experiment, to tiptoe back to those old scary places, like a child grown older who is looking in what used to be a scary closet, you do. I could be stressed or not, but I end up eating more than I need to. Joanna: You are saying that you are experiencing a rich experience of pleasure while eating. The good feeling from eating is comforting, good company, fun, entertaining. Where else in your life can you have those experiences? I invite you to think about putting more pleasure in your life that takes other forms. What are the benefits someone will derive being able to stop overeating? Joanna: A new and amazing world opens up and you can run and play and work and love in it. When you stop overeating you start feeling what you could not feel. These feelings, all of them, help you choose people, places, things, ideas, activities, that are directly related to what you genuinely care about, now that you are capable of genuinely caring. What if the people in your life were people you really wanted to be with? In my personal opinion, there is no beauty treatment that compares to health and joy. David: So many times Joanna, well-meaning people will say to the overeater: "all you have to do is not eat all the time. We have two abilities that are essential to survive. We can cry, and let our caretakers know we are in distress. So eating, taking in nourishment, hooks into the very basic feelings of survival. There is a powerful biological imperative to continue the individual life and the species that goes far beyond any emotional or intellectual decision of our adult lives. When we eat to numb ourselves we are eating to protect ourselves from feelings we cannot bear. That means that we believe in an unconscious and primitive way that we will die if we feel those feelings. So we are back in that early stage where we are taking in nourishment so we will stay alive. A person will feel (even though their mind says differently) that they will die if they stop overeating. David: Thank you Joanna for being our guest tonight and for sharing this information with us. And to those in the audience, thank you for coming and participating. We have a very large Eating Disorders community here at HealthyPlace. You will always find people interacting with various sites. Sharing the news of your eating disorder with significant others in your life. Our guest, Monika Ostroff, details her 10-year battle with anorexia in a new book Anorexia Nervosa: A Guide to Recovery. So our audience can get a sense of what you went through, please tell us a bit about yourself and what qualified you to write a book on recovery. I spent approximately 5 years in-and-out of hospitals, mostly in. Recovery for me entailed a lot of soul searching and trial and error. When I finally found some things that worked for me... I thought that some of the things that were helpful to me were bound to help others. Bob M: How old were you when your eating disorder started and how old are you now?

100mg female viagra otc

The increase in prolactin was greater in female patients cheap 50mg female viagra mastercard; the median change from baseline to endpoint for females was 1 buy discount female viagra 50mg on line. The increase in prolactin concentrations was dose-dependent (Table 5) buy female viagra 50mg overnight delivery. Table 5: Median Change in Prolactin (ng/mL) from BaselineThe proportion of patients with prolactin elevations ?-U 5s- ULN was 3. The proportion of female patients with prolactin elevations ?-U 5x ULN was 8. The proportion of male patients with prolactin elevations > 5x ULN was 1. In the uncontrolled longer-term studies (primarily open-label extension studies), Latuda was associated with a median change in prolactin of -1. Tissue culture experiments indicate that approximately one-third of human breast cancers are prolactin dependent in vitro, a factor of potential importance if the prescription of these drugs is considered in a patient with previously detected breast cancer. As is common with compounds which increase prolactin release, an increase in mammary gland neoplasia was observed in a Latuda carcinogenicity study conducted in rats and mice [see Nonclinical Toxicology (13)]. Neither clinical studies nor epidemiologic studies conducted to date have shown an association between chronic administration of this class of drugs and tumorigenesis in humans, but the available evidence is too limited to be conclusive. Leukopenia, Neutropenia and AgranulocytosisLeukopenia/neutropenia has been reported during treatment with antipsychotic agents. Agranulocytosis (including fatal cases) has been reported with other agents in the class. Possible risk factors for leukopenia/neutropenia include pre-existing low white blood cell count (WBC) and history of drug induced leukopenia/neutropenia. Patients with a pre-existing low WBC or a history of drug induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and Latuda should be discontinued at the first sign of decline in WBC, in the absence of other causative factors. Patients with neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur. Patients with severe neutropenia (absolute neutrophil count < 1000/mm3) should discontinue Latuda and have their WBC followed until recovery. Latuda may cause orthostatic hypotension, perhaps due to its ~a1-adrenergic receptor antagonism. The incidence of orthostatic hypotension and syncope events from short-term, placebo-controlled studies was (Latuda incidence, placebo incidence): orthostatic hypotension [0. Assessment of orthostatic hypotension defined by vital sign changes (?-U 20 mm Hg decrease in systolic blood pressure and ?-U 10 bpm increase in pulse from sitting to standing or supine to standing positions). In short-term clinical trials orthostatic hypotension occurred with a frequency of 0. Latuda should be used with caution in patients with known cardiovascular disease (e. Monitoring of orthostatic vital signs should be considered in patients who are vulnerable to hypotension. As with other antipsychotic drugs, Latuda should be used cautiously in patients with a history of seizures or with conditions that lower the seizure threshold, e. Conditions that lower the seizure threshold may be more prevalent in patients 65 years or older. In short-term placebo-controlled trials, seizures/convulsions occurred in < 0. Potential for Cognitive and Motor ImpairmentLatuda, like other antipsychotics, has the potential to impair judgment, thinking or motor skills. In short-term, placebo-controlled trials, somnolence was reported in 22. The frequency of somnolence increases with dose; somnolence was reported in 26. In these short-term trials, somnolence included: hypersomnia, hypersomnolence, sedation and somnolence. Patients should be cautioned about operating hazardous machinery, including motor vehicles, until they are reasonably certain that therapy with Latuda does not affect them adversely. Appropriate care is advised when prescribing Latuda for patients who will be experiencing conditions that may contribute to an elevation in core body temperature, e. The possibility of a suicide attempt is inherent in psychotic illness and close supervision of high-risk patients should accompany drug therapy. Prescriptions for Latuda should be written for the smallest quantity of tablets consistent with good patient management in order to reduce the risk of overdose. In short-term, placebo-controlled studies in patients with schizophrenia, the incidence of treatment-emergent suicidal ideation was 0. No suicide attempts or completed suicides were reported in these studies. Esophageal dysmotility and aspiration have been associated with antipsychotic drug use. Latuda is not indicated for the treatment of dementia-related psychosis, and should not be used in patients at risk for aspiration pneumonia. Clinical experience with Latuda in patients with certain concomitant systemic illnesses is limited [see Use in Specific Populations ]. Latuda has not been evaluated or used to any appreciable extent in patients with a recent history of myocardial infarction or unstable heart disease. Patients with these diagnoses were excluded from premarketing clinical studies [see Warnings and Precautions ]. Overall Adverse Reaction ProfileThe following adverse reactions are discussed in more detail in other sections of the labeling:Cerebrovascular Adverse Reactions, Including Stroke [see Warnings and Precautions ]The information below is derived from a clinical study database for Latuda consisting of over 2096 patients with schizophrenia exposed to one or more doses with a total experience of 624 patient-years. Of these patients, 1004 participated in short-term placebo-controlled schizophrenia studies with doses of 20 mg, 40 mg, 80 mg or 120 mg once daily. A total of 533 Latuda-treated patients had at least 24 weeks and 238 Latuda-treated patients had at least 52 weeks of exposure. Adverse events during exposure to study treatment were obtained by general inquiry and voluntarily reported adverse experiences, as well as results from physical examinations, vital signs, ECGs, weights and laboratory investigations. Adverse experiences were recorded by clinical investigators using their own terminology. In order to provide a meaningful estimate of the proportion of individuals experiencing adverse events, events were grouped in standardized categories using MedDRA terminology. The stated frequencies of adverse reactions represent the proportion of individuals who experienced at least once, a treatment-emergent adverse event of the type listed.

If there have been no signs of violence 50 mg female viagra for sale, most women are safe in taking a stand purchase female viagra 100 mg with amex. When they learn their partner will no longer allow it purchase female viagra 100 mg otc, some will back off. They are merely continuing a pattern they themselves learned in their childhood, most likely from their family of origin. Some emotional abusers are shocked to realize they are acting like their parents and some are willing to get help in order to stop the behavior, especially if they feel they will lose their partner if they continue to be abusive. David: Here are a few audience questions on this subject: Maera: My boyfriend just left me and I know consciously he is an abuser, but I want to call him so bad. Beverly Engel: I suggest you take this time to focus on yourself if you can. Work on revisiting your family of origin to discover why you chose an abusive partner. Try to reconnect with old friends and make new ones. Try to keep yourself occupied in positive ways instead of allowing yourself to obsess about him. Emotional abuse can be just as damaging as physical or sexual abuse and sometimes even more so because the damage is so deep and all encompassing. When you are hit, the pain will subside a lot faster than emotional abuse, which continues to go around and around in your head endlessly. There is nothing worse you can do to a person than make them doubt their sanity or their perceptions. Emotional abuse damages your self-esteem and sense of self to such a degree that many women are unable to leave the situation for fear they cannot make it on their own. If you are told every day that you are stupid, that no one else will ever want you, that you are making things up you will not have the strength and courage to believe in yourself. Yes, he refuses to believe he is abusive, then he is nice, then it starts all over again. Beverly Engel: Yes, some women find comfort in the fact that a man will never leave them. These are usually women who were abandoned in some way when they were growing up - emotionally or physically. But again, the price you pay for knowing he will never leave you can be your very sanity. Beverly Engel: Paprika - yes, this is exactly how women in an emotionally abusive relationship feel. They are afraid to say anything for fear of angering their partner. They are constantly blamed for anything that goes wrong. They feel like they have to be careful about everything they say and do. I have been in counseling three different times and the feelings go away for a bit but always come back. What can I do to really deal with them to the point that they no longer interfere with my life? Beverly Engel: oiou40 - My first question to you is why have you been in therapy 3 times? Sometimes the answer to your question is simply that you need to stay in therapy longer and keep working on the issues with your father. It takes time to overcome emotional abuse, especially if you were a child when the abuse first began. Perhaps you need more time to heal from the emotional abuse from your past and to gain more self-confidence by surrounding yourself with supportive people. It takes time to gain the courage and confidence to stand up for yourself. You can start by leaving a room or your home when the abuse begins. You can still get therapy, attend a support group, and see supportive friends without confronting the abuser. I have learned how NOT to set him off - by keeping my mouth shut. I keep telling myself I need more time also, but I keep getting depressed. Beverly Engel: Alfisher46 - Yes, when an abuser threatens to take your children they do have you where they want you, but in most cases, that is all it is - a threat. Legally, he more than likely will be unable to gain full custody of your child. She is being emotionally abused by being in his presence as he abuses you. She is learning very bad lessons about relationships by watching you and your husband interact. I know it is difficult but you do need to continue working on coming out of denial and you need to seek some help. A good therapist will help you gain the strength to leave. I am concerned about the fact that you say you are depressed. David: I remember at the start of the conference, you said emotional abuse can really wear the victim down. Beverly Engel: I suggest they seek professional help or join a support group. I am not trying to drum up business, but I do offer e-mail counseling and I am willing to help anyone who has more questions after the conference is over. Beverly also has a companion book entitled Encouragements for the Emotionally Abused Women which lets you know that you are not out there alone and is designed to lift your spirits and focus on positive growth. You can click on this link and sign up for the mail list at the top of the page, so you can keep up with events like this. I am glad you are aware of your nit picking because now you can begin to change. I suggest you look at the following possibilities:Have you become involved with someone who is rather passive and have in essence, turned the tables and are now the dominant person in the relationship?

buy female viagra 100 mg without a prescription

Neuroleptic drugs elevate prolactin levels generic female viagra 100mg without a prescription; the elevation persists during chronic administration buy 100 mg female viagra mastercard. Although disturbances such as galactorrhea cheap female viagra 50 mg amex, amenorrhea, gynecomastia, and impotence have been reported, the clinical significance of elevated serum prolactin levels is unknown for most patients. Safe use of phenothiazines in pregnancy has not been established. Most studies indicate these agents are not teratogenic but there are reports of defects in infants exposed to these drugs during the first trimester. Toxic effects observed after high doses near term include: hypotonia, lethargy, depressed reflexes, paralytic ileus, jaundice, and persistent extrapyramidal syndrome. Therefore, they should be administered cautiously to women of childbearing potential particularly during the first trimester of pregnancy and near term. Use with caution during lactation because of possible sedative and anticholinergic side effects on the infant. Chlorpromazine may adversely affect many of the conditions commonly occurring in the aged, including cardiovascular problems, parkinsonian extrapyramidal effects and anticholinergic effects (e. Dependence and Withdrawl: In general, phenothiazines do not produce psychic dependence; however, gastritis, nausea and vomiting, dizziness, and tremulousness have been reported following abrupt cessation of high dose therapy. Reports suggest that these symptoms can be reduced if concomitant antiparkinsonian agents are continued for several weeks after the phenothiazine is withdrawn. Interference with cognitive and motor performance: Where patients are participating in activities requiring complete mental alertness such as driving an automobile or operating machinery, administer the phenothiazine cautiously, forewarn the patient and increase the dosage gradually. Patients should utilize sunscreens when exposed to sunlight for significant lengths of time. Amphetamines: Amphetamines may cause exacerbation of psychotic symptoms. Antacids: May impair the absorption of chlorpromazine. Anticonvulsants: Chlorpromazine may lower the seizure threshold. Anticonvulsant therapy should be monitored closely and may require dosage adjustment. Antidepressants, tricyclic: May result in increased chlorpromazine concentration, monitor for adverse effects. CNS Depressants: Chlorpromazine and other CNS depressants (alcohol, antihistamines, general anesthetics, opiates or other narcotic analgesics, barbiturates, benzodiazepines and other sedative/hypnotic agents) may result in additive CNS depressant effects. Monitor to avoid excessive sedation or respiratory depression. Epinephrine: Patients on chlorpromazine who are hypotensive should not be given epinephrine. Chlorpromazine blocks peripheral alpha-adrenergic receptors, thereby inhibiting alpha-agonist effects of epinephrine such as vasoconstriction and increased blood pressure. The beta-agonist effects of epinephrine (vasodilation) may be left unopposed and a further fall in blood pressure may result. Agents such as phenylephrine methoxamine or norepinephrine may be a suitable alternative to raise blood pressure. Hypotensive Agents: Chlorpromazine and antihypertensives may result in additive hypotensive effects and increased risk of orthostatic hypotension or syncope (fainting). Chlorpromazine may block the antihypertensive effects of guanethidine by preventing its uptake into sympathetic nerves. Levodopa: Phenothiazines may inhibit the antiparkinsonian effects of levodopa due to their dopamine blocking effects in the CNS. Generally, phenothiazines should not be administered to patients who require levodopa. Lithium: Patients receiving lithium and chlorpromazine for treatment of acute mania should be monitored closely for signs of adverse neurologic effects, especially if serum concentrations of lithium are in the upper range. Rare cases of severe neurotoxicity have been reported. BEFORE USING THIS MEDICINE: INFORM YOUR DOCTOR OR PHARMACIST of all prescription and over-the-counter medicine that you are taking. This includes meperidine, diazoxide, guanethidine, medicines used to treat high blood pressure and heart conditions, medicines used to treat depression, and medicines used to treat bladder or bowel spasms. Inform your doctor of any other medical conditions including seizure disorders, depression, allergies, pregnancy, or breast-feeding. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience changes in vision; changes in breasts; changes in menstrual period; sore throat; inability to move eyes; muscle spasms of face, neck, or back; difficulty swallowing; mask-like face; tremors of hands; restlessness; tension in legs; shuffling walk or stiff arms or legs; puffing of cheeks; lip smacking or puckering; twitching or twisting movements; or weakness of arms or legs. Do not become overheated in hot weather, during exercise, or other activities since heat stroke may occur while you are using this medicine. This medicine may cause increased sensitivity to the sun. Avoid exposure to the sun or sunlamps until you know how you react to this medicine. Use a sunscreen or protective clothing if you must be outside for a prolonged period. In general, members of the aliphatic group of phenothiazines have strong sedative, hypotensive and anticholinergic properties and mild to moderate extrapyramidal effects. Automatic Nervous System: Anticholinergic effects including dry mouth, blurred vision, constipation, ileus, nasal stuffiness, photophobia. Syncope and impaired temperature regulation have also occurred. Cardiovascular: Chlorpromazine has peripheral alpha-adrenergic blocking activity. Its effects on the heart include: direct negative inotropic and quinidine-like actions. Its effects on the ECG include prolongation of the PR and QT intervals, blunting of the T wave and depression of the S-T segment. Ventricular arrythmia and sudden death have occurred rarely. Orthostatic hypotension is common after parenteral administration and usually lasts one-half to 2 hours.

Psychologically abusive relationships buy generic female viagra 100 mg, such as those in a marriage cheap 50mg female viagra with visa, are common because both parties are typically dedicated to keeping the relationship together buy female viagra 100 mg on-line. The abuser may wish to continue the relationship in order to exercise control over their partner, while the abused may stay in the relationship due to vows taken and esteem that has been worn away due to the abuse. Psychological abuse does not revolve around one topic. Psychological abuse in relationships may be about:Emotion ??? "Stop being so emotional all the time. Moreover, this decrease in worth makes it more likely that a person will stay with their abuser as they begin to believe the abusive things their partner says and believe they deserve nothing more. As Kelly Holly, author of the Verbal Abuse in Relationships Blog, points out, verbal psychological abuse can take many forms. Psychological abuse may be prominent during arguments but can also occur in day-to-day situations. I can feel myself being pulled into hell just listening to your nonsense! Emotional and mental abuse happens to both children and adults. When other forms of abuse such as sexual abuse or physical abuse take place, mental abuse is almost always additionally present. Even in cases of childhood emotional abuse, perpetrators are rarely charged as it is very difficult to prove if other types of abuse are not also present. Children are often victims of emotional and mental abuse and neglect. This may include constant criticism, threats, or rejection, as well as withholding love, support, or guidance. Feelings of being worthless or damaged in some way ??? emotionally abused children are typically told they are no good so frequently that they come to believe it. This can lead to unfulfilling adult roles as the person feels they are not worth a good education or job. Trouble regulating emotions ??? because emotionally abused children are often punished for expressing their emotions, they never learn how to express them in a reasonable, safe way. This leads to emotions coming out in unpredictable ways such as in anger, depression or anxiety. While children often physically cannot escape their abuser, many adults feel as though they cannot escape their abuser either. Signs of mental abuse in relationships take many forms. Mental abuse symptoms can revolve around: Dominance ??? the abuser needs to feel in charge of the relationshipHumiliation ??? the abuser puts their partner down by embarrassing themIsolation ??? the abuser segregates their partner from others in order to increase dependenceThreats ??? the abuser makes threats to make their partner feel unsafeIntimidation ??? the abuser indicates that if you do not obey, there will be dire consequencesDenial and blame ??? the abuser denies the abuse and blames their partner for "making" them do itMentally abusive relationships can be of any type and involve either gender. While abuse of women is widely known, what is not widely recognized is that men can be victims of emotional abuse too. And emotional abuse of men is every bit as unacceptable as emotional abuse of women. In domestic abuse, about 40% of cases involve violence of women against men. Emotional abuse of men is the same as emotional abuse of women: it is acts, including verbal assault, that make a person feel less self-worth or dignity. Emotional abuse of men makes them feel like less of a person. Male victims of emotional abuse may experience partners that:Threaten them and try to induce fearInsult and demean them; tell them they are not worth the troubleLie or withhold informationTreat them like a child or servantControl all the financesSome believe that men are more sensitive to emotional abuse than woman and can "brush off" physical abuse more easily. Male victims of emotional abuse who are called a "coward," "impotent," or a "failure," may be more affected by these remarks than their female counterparts. He may not believe he is worthy enough to leave the relationship or he may believe he deserves the emotional abuse. Men may also stay in emotionally abusive relationships because:Of threats made by their abuserThey feel dependent on the abuserUnfortunately, due to lack of awareness, programs for male victims of emotional abuse are almost nonexistent. However, private counselling and general anti-violence advocacy groups may be helpful. Male victims of emotional abuse can:Call the National Domestic Abuse Hotline at 1-800-799-SAFECall the Child Abuse Hotline at 1-800-4-A-CHILDMale victims of emotional abuse should also:Leave the relationship, if possibleTell others about the abuseKeep evidence of abuse for possible legal actionsEmotional abuse in relationships, marriage, is sneaky because while abuse is taking place, no physical marks or scars ever appear. Often the only sign that something is wrong in emotionally abusive relationships is just a feeling that something is amiss. Emotional abuse in any relationship, including marriage, has the same dynamic. The perpetrator aims to gain power and control over the victim. The abuser does this though belittling, threatening or manipulative behavior. Abusive behavior can be enacted by a female or male and either a female or male can be a victim. Tragically, this keeps victims in emotionally abusive relationships as they feel they have no way out and that they are nothing without their abuser. Emotional abuse comes in many forms, they include: Financial abuse ??? the abuser does not allow the victim control over any of the financesName-calling, blaming and shaming ??? forms of humiliationIsolation ??? controlling access to friends and familyDenial and blame ??? denying or minimizing the abuse or blaming the victim; saying that the victim "made them do it"These emotionally abusive behaviors seen in relationships, marriages, are all used in an attempt to control the victim. Signs of an emotionally abusive relationship can sometimes be seen more easily from the inside out. Assessing an emotionally abusive relationship may first start with how you feel about the relationship and then move on to actually dissecting the nature of the abuse. In fact, depending on how far the emotional abuse has gone, this may be the only option, no matter how impossible a task it may seem. In more minor cases of emotional abuse though, other options may be available. Standing up against the emotional abuse and no longer being a willing party to it may lead to a change in the relationship dynamic. Dealing with emotional abuse is something that many men and women face in relationships. The first step in dealing with emotional abuse is learning to spot the signs.

purchase 100 mg female viagra with amex

Anyone considering the use of SEROQUEL or any other antidepressant in a child proven 50 mg female viagra, adolescent generic 100mg female viagra fast delivery, or young adult must balance this risk with the clinical need cheap 50 mg female viagra free shipping. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. SEROQUEL is not approved for use in pediatric patients. The efficacy of SEROQUEL was established in two identical 8-week randomized, placebo-controlled double-blind clinical studies that included either bipolar I or II patients [see CLINICAL PHARMACOLOGY ]. Effectiveness has not been systematically evaluated in clinical trials for more than 8 weeks. The efficacy of SEROQUEL in acute bipolar mania was established in two 12-week monotherapy trials and one 3-week adjunct therapy trial of bipolar I patients initially hospitalized for up to 7 days for acute mania [see CLINICAL PHARMACOLOGY ]. Effectiveness has not been systematically evaluated in clinical trials for more than 12 weeks in monotherapy. Maintenance Treatment in Bipolar DisorderThe efficacy of SEROQUEL as adjunct maintenance therapy to lithium or divalproex was established in 2 identical randomized placebo-controlled double-blind studies in patients with Bipolar I Disorder. SEROQUEL is indicated for the treatment of schizophrenia. The efficacy of SEROQUEL in schizophrenia was established in short-term (6-week) controlled trials of schizophrenic inpatients [see CLINICAL PHARMACOLOGY ]. The effectiveness of SEROQUEL in long-term use, that is, for more than 6 weeks, has not been systematically evaluated in controlled trials. Therefore, the physician who elects to use SEROQUEL for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient [see DOSAGE AND ADMINISTRATION ]. Usual Dose: SEROQUEL should be administered once daily at bedtime to reach 300 mg/day by day 4. In these clinical trials supporting effectiveness, the dosing schedule was 50 mg, 100 mg, 200 mg and 300 mg/day for days 1-4 respectively. Patients receiving 600 mg increased to 400 mg on day 5 and 600 mg on day 8 (Week 1). Antidepressant efficacy was demonstrated with SEROQUEL at both 300 mg and 600 mg however, no additional benefit was seen in the 600 mg group. Usual Dose: When used as monotherapy or adjunct therapy (with lithium or divalproex), SEROQUEL should be initiated in bid doses totaling 100 mg/day on Day 1, increased to 400 mg/day on Day 4 in increments of up to 100 mg/day in bid divided doses. Further dosage adjustments up to 800 mg/day by Day 6 should be in increments of no greater than 200 mg/day. Data indicate that the majority of patients responded between 400 to 800 mg/day. The safety of doses above 800 mg/day has not been evaluated in clinical trials. Maintenance of efficacy in Bipolar I Disorder was demonstrated with SEROQUEL (administered twice daily totalling 400 to 800 mg per day) as adjunct therapy to lithium or divalproex. Generally, in the maintenance phase, patients continued on the same dose on which they were stabilized during the stabilization phase. Usual Dose: SEROQUEL should generally be administered with an initial dose of 25 mg bid, with increases in increments of 25-50 mg bid or tid on the second and third day, as tolerated, to a target dose range of 300 to 400 mg daily by the fourth day, given bid or tid. Further dosage adjustments, if indicated, should generally occur at intervals of not less than 2 days, as steady-state for SEROQUEL would not be achieved for approximately 1-2 days in the typical patient. When dosage adjustments are necessary, dose increments/decrements of 25-50 mg bid are recommended. Most efficacy data with SEROQUEL were obtained using tid regimens, but in one controlled trial 225 mg twice per day was also effective. Efficacy in schizophrenia was demonstrated in a dose range of 150 to 750 mg/day in the clinical trials supporting the effectiveness of SEROQUEL. In a dose response study, doses above 300 mg/day were not demonstrated to be more efficacious than the 300 mg/day dose. In other studies, however, doses in the range of 400-500 mg/day appeared to be needed. The safety of doses above 800 mg/day has not been evaluated in clinical trials. Consideration should be given to a slower rate of dose titration and a lower target dose in the elderly and in patients who are debilitated or who have a predisposition to hypotensive reactions [see CLINICAL PHARMACOLOGY ]. When indicated, dose escalation should be performed with caution in these patients. Patients with hepatic impairment should be started on 25 mg/day. The dose should be increased daily in increments of 25-50 mg/day to an effective dose, depending on the clinical response and tolerability of the patient. The elimination of quetiapine was enhanced in the presence of phenytoin. Higher maintenance doses of quetiapine may be required when it is coadministered with phenytoin and other enzyme inducers such as carbamazepine and phenobarbital [see DRUG INTERACTIONS ]. While there is no body of evidence available to answer the question of how long the patient treated with SEROQUEL should be maintained, it is generally recommended that responding patients be continued beyond the acute response, but at the lowest dose needed to maintain remission. Patients should be periodically reassessed to determine the need for maintenance treatment. Although there are no data to specifically address reinitiation of treatment, it is recommended that when restarting patients who have had an interval of less than one week off SEROQUEL, titration of SEROQUEL is not required and the maintenance dose may be reinitiated. When restarting therapy of patients who have been off SEROQUEL for more than one week, the initial titration schedule should be followed. There are no systematically collected data to specifically address switching patients with schizophrenia from antipsychotics to SEROQUEL, or concerning concomitant administration with antipsychotics. While immediate discontinuation of the previous antipsychotic treatment may be acceptable for some patients with schizophrenia, more gradual discontinuation may be most appropriate for others. In all cases, the period of overlapping antipsychotic administration should be minimized. When switching patients with schizophrenia from depot antipsychotics, if medically appropriate, initiate SEROQUEL therapy in place of the next scheduled injection.